wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38392676-2BE5714F-6429-4954-B271-8417C8F639A5
Q38392676-2BE5714F-6429-4954-B271-8417C8F639A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38392676-2BE5714F-6429-4954-B271-8417C8F639A5
A review of the European LeukemiaNet recommendations for the management of CML.
P2860
Q38392676-2BE5714F-6429-4954-B271-8417C8F639A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38392676-2BE5714F-6429-4954-B271-8417C8F639A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
09206631aad4e09fd8516f98f946fbd2ffa67eed
P2860
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.